From: Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection
Treatment group
Survival % (live/treated)
WNV control
58 (7/12)
Dexamethasone
19 (3/16)a
Dex + WNIG (1.0 mg/mouse)
100 (17/17)
Dex + WNIG (0.2 mg/mouse)
100 (16/16)